-+ 0.00%
-+ 0.00%
-+ 0.00%

Insights into Catalyst Pharmaceuticals Q4 Earnings

Benzinga·02/25/2026 21:16:23
Listen to the news

The Q4 earnings report for Catalyst Pharmaceuticals (NASDAQ:CPRX) was released on Wednesday, February 25, 2026 at 04:16 PM.

Here's what investors need to know about the latest announcement.

Earnings

Catalyst Pharmaceuticals beat estimated earnings by 38.78%, reporting an EPS of $0.68 versus an estimate of $0.49.

Revenue was up $10.69 million from the same period last year.

Previous Earnings Records

The company beat on EPS by $0.17 in the last quarter, resulting in a 1.82% drop share price change the following day.

Here's a look at Catalyst Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.51 0.55 0.53 0.55
EPS Actual 0.68 0.68 0.68 0.70
Revenue Estimate 136.65M 139.94M 130.86M 134.20M
Revenue Actual 148.39M 146.56M 141.42M 141.81M

To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.